Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in Relapsed/Refractory Multiple Myeloma
NCT02079519Phase 2Terminated
- Sponsor
- Roche
- Start
- May 2006
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in multiple myeloma (MM), sponsored by Roche. Started May 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02079519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079519.